GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › SERA growth analysis
Growth stock analysis · updated 2026-07-28

Sera Prognostics, Inc. Class A Common Stock (SERA) growth stock analysis

Is Sera Prognostics, Inc. Class A Common Stock a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
16
Growth score
20
RS rating
#4,123
Rank
0/6
Traits passed
16/99
Growth score · 4123rd of 4,892 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about SERA

As of the 2026-07-28 close, SERA scores 16 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 4123rd of 4,892 rated US stocks, the top 84% of the market.

Its strongest trait is I (institutional sponsorship) at 55, and its weakest is A (annual earnings growth) at 0. SERA clears 0 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, SERA carries a lagging Relative Strength rating of 20, meaning it has outperformed about 20% of the market over the past year.

Underneath the score: sales down 63%, trading 46% below its 52-week high.

SERA growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
22
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
2
S
Supply & demand
volume behind the move vs. share supply
41
L
Leader or laggard
Relative Strength within its group
39
I
Institutional sponsorship
fund accumulation and 13F ownership
55

Is SERA a growth stock?

Not right now by CANSLIM

On today’s data SERA does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than SERA

The stocks ranking above SERA today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 SERA price history & buy range

Where SERA sits in its base, its 52-week path, and the trait trend over the past year.

Open the full SERA profile →

See where SERA ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

SERA as a growth stock, frequently asked

Is SERA a good growth stock?

Not right now by CANSLIM. On today’s data SERA does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is SERA's growth score?

Sera Prognostics, Inc. Class A Common Stock (SERA) scores 16 out of 99 on our growth-stock rating as of the 2026-07-28 close, ranking 4123rd of 4,892 rated US stocks.

Does SERA have strong earnings growth?

We don't have current earnings-growth figures for SERA.

How strong is SERA's price performance?

SERA has a Relative Strength rating of 20, meaning it has outperformed roughly 20% of the US market over the trailing year.

Where can I see SERA's full analysis?

Create a free Growth Stock Analyzer account to see where SERA ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Services-Medical Laboratories